JOHNSON & JOHNSON
16 holdingsFiling period: 2026-03-31Current AUM: $785.0Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics Inc. | 2.45M | $258.1M | $334.7M | 42.63% | -- | 2026-03-31 |
| 2 | NBTX | Nanobiotix S.A. | 5.62M | $173.6M | $215.9M | 27.50% | -- | 2026-03-31 |
| 3 | — | MeiraGTx Holdings plc | 6.64M | $57.5M | $57.5M | 7.33% | -- | 2026-03-31 |
| 4 | RAPP | Rapport Therapeutics, Inc. | 1.78M | $55.8M | $73.1M | 9.32% | -- | 2026-03-31 |
| 5 | CVRX | CVRx, Inc. | 4.02M | $38.1M | $20.8M | 2.65% | -- | 2026-03-31 |
| 6 | CTNM | Contineum Therapeutics Inc. | 1.98M | $25.8M | $30.7M | 3.91% | -- | 2026-03-31 |
| 7 | LEGN | Legend Biotech Corporation | 814.6K | $14.7M | $15.1M | 1.92% | -- | 2026-03-31 |
| 8 | XNCR | Xencor, Inc. | 748.1K | $9.0M | $15.1M | 1.93% | -- | 2026-03-31 |
| 9 | PRCT | Procept BioRobotics Corporation | 357.9K | $9.0M | $6.7M | 0.85% | -- | 2026-03-31 |
| 10 | FATE | Fate Therapeutics, Inc. | 3.38M | $4.1M | $8.3M | 1.05% | -- | 2026-03-31 |
| 11 | NMRA | Neumora Therapeutics, Inc. | 1.85M | $3.6M | $3.0M | 0.38% | -- | 2026-03-31 |
| 12 | RLYB | Rallybio Corporation | 152.9K | $1.4M | $2.4M | 0.31% | -- | 2026-03-31 |
| 13 | VOR | Vor Biopharma, Inc. | 53.7K | $958K | $1.1M | 0.14% | -- | 2026-03-31 |
| 14 | LAB | Standard BioTools, Inc. | 312.0K | $286K | $270K | 0.03% | -- | 2026-03-31 |
| 15 | — | Nano-X Imaging Ltd. | 83.6K | $189K | $189K | 0.02% | -75,298 | 2026-03-31 |
| 16 | ACET | Adicet Bio, Inc. | 22.8K | $155K | $207K | 0.03% | -- | 2026-03-31 |
← Scroll →